Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: QuietWon who wrote (206)	1/12/1999 12:38:00 AM
From: JEB	Read Replies (2) of 2515

QW, I'm sorry, I was wrong on my last post to you. The C225 proposals are to go to FDA for phase III approval anytime now. The BEC2 is in phase III trials for lung cancer but I have since found that it is being used for patients this year on Kaposi's Sarcoma: imclone.com Also, they have been able to isolate vascular stem cells and are studying therapy for repairing diseased or damaged blood vessels: go2net.newsalert.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next